EDGAR Filing Documents for 0001819790-24-000085

Form 4 - Statement of changes in beneficial ownership of securities:

SEC Accession No. 0001819790-24-000085

Filing Date

2024-06-14

Accepted

2024-06-14 17:45:39

Documents

Period of Report

2024-06-13

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 4	wk-form4_1718401530.html	4
1	FORM 4	wk-form4_1718401530.xml	4	6517
2	EX-24	tarsus-powerofattorneyan.htm	EX-24	4120
3	GRAPHIC	tarsus-powerofattorneyan001.jpg	GRAPHIC	208256
	Complete submission text file	0001819790-24-000085.txt		299023

Mailing Address 15440 LAGUNA CANYON ROAD IRVINE CA 92618

Business Address 15440 LAGUNA CANYON ROAD IRVINE CA 92618 (949) 409-9820

Tarsus Pharmaceuticals, Inc. (Issuer) CIK: 0001819790 (see all company filings)

IRS No.: 814717861 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 15440 LAGUNA CANYON ROAD, SUITE 160 IRVINE CA 92618

Business Address

Goldberg Andrew D. (Reporting) CIK: 0001827722 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39614 | Film No.: 241046230